009300 — Sam-A Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	10,197	124	3,392	11,912	21,374
Depreciation
Amortisation
Non-Cash Items	474	3,992	2,833	6,516	2,279
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,658	1,401	3,019	-2,010	-6,788
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	13,221	9,408	12,943	19,604	20,760
Capital Expenditures	-492	-680	-275	-239	-3,820
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-21,478	482	-19,521	-12,793	-16,987
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-21,971	-198	-19,796	-13,032	-20,807
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-677	-3,665	-3,670	-5,381	-112
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-9,423	5,397	-10,411	1,191	-156